CTLA4 and cancer: The immune memory protected mice from cancer recurrence, as demonstrated by the ability of anti-CTLA4 therapy in conjunction with PLGA–ICG–R837–based photothermal treatment to protect treated mice from tumor cells rechallenged 40 days after first tumor ablation.